Page last updated: 2024-11-05

chloroacetamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Chloroacetamide is a white crystalline solid that is used as a herbicide. It is synthesized by reacting chloroacetyl chloride with ammonia. Chloroacetamide inhibits plant growth by interfering with the synthesis of amino acids. It is important because it is used to control weeds in a variety of crops. Chloroacetamide is studied because it is a potential environmental contaminant and has been shown to have toxic effects on aquatic organisms. However, further research is needed to assess its potential risks to human health.'

Cross-References

ID SourceID
PubMed CID6580
CHEMBL ID346368
MeSH IDM0061989

Synonyms (66)

Synonym
wln: zv1g
.alpha.-chloroacetamide
nsc-8408
chloracetamide
usaf do-29
chloroacetamide ,
chloracetamid
nsc8408
mergal af
microcide
2-chloroethanamide
79-07-2
2-chloroacetamide
acetamide, 2-chloro-
nsc54286
nsc-54286
chloracetamid [german]
brn 0878191
ai3-60133
einecs 201-174-2
2-chloracetamide
hsdb 7449
nsc 54286
acetic acid,chloro,amide
inchi=1/c2h4clno/c3-1-2(4)5/h1h2,(h2,4,5
STK298897
2-chloroacetamide, >=98%
2-chloroacetamide, >=98.0% (hplc)
AKOS000104694
FT-0664531
CHEMBL346368 ,
2-chloro-acetamide
C2536
ec 201-174-2
unii-2r97846t1l
2r97846t1l ,
FT-0611896
chloroacetamide [mart.]
chloroacetamide [hsdb]
chloroacetamide [mi]
chloroacetamide [inci]
chloroacetamide-d4
2-chloroacetic acid amide
2--chloroacetamide
a-chloroacetamide
clch2conh2
monochloroacetamide
alpha-chloroacetamide
NCGC00357244-01
dtxcid7021570
cas-79-07-2
tox21_304037
dtxsid9041570 ,
STR00268
acetamide, .alpha.-chloro-
.alpha.-chloracetamide
mfcd00008027
J-509001
F2190-0195
Q209345
bdbm50226182
CS-W011345
AMY4113
HY-W010629
EN300-18249
PD194639

Research Excerpts

Overview

Chloroacetamide (CAA) is a preservative used in various cosmetic, personal care and household products. CAA is an uncommon skin care product allergen.

ExcerptReferenceRelevance
"Chloroacetamide (CAA) is a preservative used in various cosmetic, personal care and household products. "( LC-APCI-MS/MS Quantification and Topical Bioavailability of Chloroacetamide in Rats.
Choi, YK; Kim, KB; Kim, MG; Kim, MK; Kim, SM; Kim, TH; Lee, JP; Seok, SH; Shin, BS; Yoo, SD, 2015
)
2.1
"Chloroacetamide is an uncommon skin care product allergen. "( Contact allergy to chloroacetamide.
Delaney, TA; Taran, JM, 1997
)
2.07

Actions

ExcerptReferenceRelevance
"Chloroacetamide herbicides inhibit very-long-chain fatty acid elongase, and it has been suggested that covalent binding to the active site cysteine of the condensing enzyme is responsible [Pest Manage Sci 56 (2000), 497], but direct evidence was not available. "( Covalent binding of chloroacetamide herbicides to the active site cysteine of plant type III polyketide synthases.
Böger, P; Eckermann, C; Lederer, B; Matthes, B; Nimtz, M; Reiser, V; Schröder, J, 2003
)
2.09

Toxicity

ExcerptReferenceRelevance
" This suggests that toxic photodegradation products are generated from chloroacetamides under UV-treatment."( Identification and ecotoxicity of degradation products of chloroacetamide herbicides from UV-treatment of water.
Andersen, HR; Bouchonnet, S; Bourcier, S; Kusk, KO; Sablier, M; Souissi, Y, 2013
)
0.87

Bioavailability

ExcerptReferenceRelevance
" This study describes the development of a highly specific and sensitive atmospheric pressure chemical ionization tandem mass spectrometry method for the determination of CAA in rat plasma and its application to a topical bioavailability study."( LC-APCI-MS/MS Quantification and Topical Bioavailability of Chloroacetamide in Rats.
Choi, YK; Kim, KB; Kim, MG; Kim, MK; Kim, SM; Kim, TH; Lee, JP; Seok, SH; Shin, BS; Yoo, SD, 2015
)
0.66

Dosage Studied

ExcerptRelevanceReference
" The main aims of the present study were (1) to assess if stress-induced Hsp70 could be used to monitor exposure of the earthworm species Lumbricus terrestris to various soil pollutants, (2) to assess the specificity of pollutants in their tissue targeting and in Hsp70 induction, and (3) to evaluate if dose-response relationships could be established and if the stress-response observed was specific."( Evaluation for Hsp70 as a biomarker of effect of pollutants on the earthworm Lumbricus terrestris.
Corneau, S; Morrow, G; Nadeau, D; Plante, I; Tanguay, RM, 2001
)
0.31
"This paper presents a simple, specific, and precise high-performance liquid chromatographic method for the simultaneous determination of paracetamol (PCM), chlorzoxazone (CXZ), and their related impurities in bulk raw materials and solid dosage forms."( Simultaneous determination of paracetamol, chlorzoxazone, and related impurities 4-aminophenol, 4'-chloroacetanilide, and p-chlorophenol in pharmaceutical preparations by high-performance liquid chromatography.
Ali, MS; Ghori, M; Kahtri, AR; Rafiuddin, S,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency9.34940.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency61.13060.000221.22318,912.5098AID1259243
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency27.30600.001022.650876.6163AID1224838; AID1224893
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency30.63790.001530.607315,848.9004AID1224841; AID1259401
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency0.06160.057821.109761.2679AID1159526; AID1159528
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Alcohol dehydrogenase E chainEquus caballus (horse)Ki7,585.77980.14122.89278.7000AID33855
Alcohol dehydrogenase S chainEquus caballus (horse)Ki7,585.77980.14122.89278.7000AID33855
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1133220Toxicity in ip dosed BDF1 mouse assessed as animal killed administered as single dose1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Haloacetamido analogues of 2-amino-2-deoxy-D-glucose and 2-amino-2-deoxy-D-galactose. Syntheses and effects on the Friend murine erythroleukemia.
AID1133228Antitumor activity against DBA/2J mouse Friend erythroleukemia cells allografted ip dosed DBA/2 mouse assessed as increase in host survival time administered on days 1, 2 and 3 after tumor transplantation1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Haloacetamido analogues of 2-amino-2-deoxy-D-glucose and 2-amino-2-deoxy-D-galactose. Syntheses and effects on the Friend murine erythroleukemia.
AID1133221Antiproliferative activity against DBA/2J mouse Friend erythroleukemia cells after 3 days by cell counter1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Haloacetamido analogues of 2-amino-2-deoxy-D-glucose and 2-amino-2-deoxy-D-galactose. Syntheses and effects on the Friend murine erythroleukemia.
AID23467Partition coefficient (logP)1986Journal of medicinal chemistry, May, Volume: 29, Issue:5
A quantitative structure-activity relationship and molecular graphics analysis of hydrophobic effects in the interactions of inhibitors with alcohol dehydrogenase.
AID33855Inhibitory activity against horse liver alcohol dehydrogenase (ADH)1986Journal of medicinal chemistry, May, Volume: 29, Issue:5
A quantitative structure-activity relationship and molecular graphics analysis of hydrophobic effects in the interactions of inhibitors with alcohol dehydrogenase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (99)

TimeframeStudies, This Drug (%)All Drugs %
pre-199022 (22.22)18.7374
1990's10 (10.10)18.2507
2000's19 (19.19)29.6817
2010's25 (25.25)24.3611
2020's23 (23.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.41 (24.57)
Research Supply Index4.67 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index71.02 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (47.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.94%)6.00%
Case Studies19 (17.92%)4.05%
Observational0 (0.00%)0.25%
Other86 (81.13%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]